Evercore ISI Forecasts Strong Price Appreciation for GE HealthCare Technologies (NASDAQ:GEHC) Stock

GE HealthCare Technologies (NASDAQ:GEHC) had its price objective hoisted by investment analysts at Evercore ISI from $95.00 to $98.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Evercore ISI’s target price suggests a potential upside of 17.86% from the company’s current price.

Several other equities research analysts also recently issued reports on the company. Citigroup raised their price target on GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Stifel Nicolaus upped their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a report on Wednesday. BTIG Research boosted their target price on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research report on Wednesday. Wells Fargo & Company raised their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research report on Thursday. Finally, Piper Sandler boosted their price objective on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, January 30th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies presently has an average rating of “Hold” and a consensus target price of $92.42.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock traded up $0.52 during trading on Thursday, reaching $83.15. The company had a trading volume of 1,757,003 shares, compared to its average volume of 3,580,333. GE HealthCare Technologies has a one year low of $57.65 and a one year high of $94.80. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The firm’s 50 day simple moving average is $82.68 and its two-hundred day simple moving average is $77.47. The company has a market capitalization of $37.88 billion, a PE ratio of 17.18, a PEG ratio of 2.38 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. During the same period in the previous year, the company earned $1.45 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts forecast that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the company. Allianz SE lifted its position in GE HealthCare Technologies by 165.2% during the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after acquiring an additional 218 shares during the period. E Fund Management Hong Kong Co. Ltd. raised its stake in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after purchasing an additional 196 shares during the last quarter. Godsey & Gibb Inc. purchased a new position in shares of GE HealthCare Technologies in the third quarter worth about $26,000. Laurel Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $26,000. Finally, Optima Capital LLC purchased a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Institutional investors own 82.06% of the company’s stock.

Key GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Q4 results beat — GE HealthCare reported $1.44 EPS and $5.70B revenue, both topping estimates and showing 7.1% revenue growth, supporting investor optimism. GE HealthCare reports fourth quarter and full year 2025 financial results
• Positive Sentiment: FY‑2026 guidance nudges above consensus — GEHC set FY‑26 EPS guidance of $4.95–$5.15 versus a ~$4.93 consensus, which reinforces the beat as more than one quarter of strength. GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices
• Positive Sentiment: Analyst price‑target upgrades — Wells Fargo raised its PT to $97 (overweight) and BTIG lifted its PT to $91 (buy), signaling institutional confidence and creating incremental upside pressure. Benzinga
• Positive Sentiment: Regulatory win for Allia Moveo — FDA and CE clearance for the Allia Moveo mobile C‑arm (AI guidance, compact design) supports product commercialization and future revenue growth. GEHC Wins FDA Clearance & CE Mark for Allia Moveo, Marks Global Debut
• Neutral Sentiment: Earnings call & transcript available — Management commentary and the transcript provide more color on growth drivers (Imaging, PDx) and cost items; useful for gauging sustainability of the beat. GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Company materials posted — Press release, slide deck and call recording are available for investors who want the detailed metrics and segment disclosures. GE HealthCare earnings materials
• Negative Sentiment: Margins under pressure — Net margin declined due to tariffs and an unfavorable product mix, a headwind that could cap multiple expansion until costs normalize. GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls
• Negative Sentiment: Profit fell year‑over‑year — Coverage noted that GAAP profit declined despite higher revenue, which keeps some investors cautious about near‑term profitability. GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.